AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.
Also called NCT06123130
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 198 participants
- Sponsor
- HeartBeam, Inc.
- Registry
-
NCT06123130
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT06123130. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-03-13 (actual); primary completion 2024-06-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection
- Acronym
- VALID-ECG
- Condition
- Arrhythmias, Cardiac
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Condition
- Bradycardia
- Condition
- Tachycardia
- Intervention (Device)
- Vectorcardiography (VECG)
- Lead sponsor
- HeartBeam, Inc.
Record details
- Record id
cardio:ct-nct06123130- Content hash
14ddcc0de6cb18b41e57454c114f7286943276084ca066447c399319c95ba4dd